Charles Peloquin

Charles Peloquin, Pharm.D.

Professor

Department: Pharmacotherapy & Translational Research
Business Phone: (352) 273-6266
Business Email: peloquin@cop.ufl.edu

About Charles Peloquin

Prior to coming to the University of Florida, Dr. Peloquin completed a hospital pharmacy residency at Duke University Medical Center, where he also served on the clinical staff. He also completed a fellowship in Infectious Diseases and Pharmacokinetics at the Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital, Buffalo, N.Y. For 20 years, Dr. Peloquin was the Director of the Infectious Disease Pharmacokinetics Laboratory (IDPL) at National Jewish Medical and Research Center, Denver, CO. He now serves as Professor of Pharmacy and Medicine at UF, where the IDPL is now located. Dr. Peloquin and his lab are part of the UF Emerging Pathogens Institute. He also is a consultant to the FDA and CDC.

Accomplishments

Member
2004-Current · International Society of Antimicrobial Pharmacology
Member
1991-Current · Society of Infectious Disease Pharmacists
Member
1990-Current · American Society of Microbiology
Member
1986-Current · American College of Clinical Pharmacy

Research Profile

Dr. Peloquin’s laboratory serves as a national reference center for the determination of serum concentrations for the antimycobacterial, antifungal, and anti-HIV drugs, as well as linezolid. His research efforts focus on therapeutic drug monitoring and clinical trials for patients with advanced mycobacterial diseases.

Publications

2020 Journal of the Pediatric Infectious Diseases Society (Online)
2019 ˜The œinternational journal of tuberculosis and lung disease (Online)
2019 American Journal of Respiratory and Critical Care Medicine
2019 American Journal of Respiratory and Critical Care Medicine
2019 American Journal of Respiratory and Critical Care Medicine
2019 New England Journal of Medicine
2018 Antimicrobial agents and chemotherapy
2015 Clinical Pharmacology & Therapeutics
2012 Expert Opinion on Pharmacotherapy
2011 American Journal of Respiratory and Critical Care Medicine

Grants

Nov 2019 ACTIVE
LegoChem Data Analysis – Task Order #1
LEGOCHEM BIOSCIENCES · Principal Investigator
May 2019 ACTIVE
Development of Gleevec for TB and TB/HIV
EMORY UNIV · Principal Investigator
Apr 2019 – Apr 2020
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
RUTGERS STATE UNIV · Principal Investigator
Feb 2019 ACTIVE
Diagnostics and Pharmacotherapy for Severe Forms of TB
UNIV OF VIRGINIA · Principal Investigator
Sep 2018 ACTIVE
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
NATL INST OF HLTH NICHD ·
Jul 2018 ACTIVE
An Exploratory Study of Anti-Tuberculosis Drug Penetration into Cerebrospinal Fluid
EMORY UNIV · Principal Investigator
Feb 2018 – Jan 2019
Diagnostics and Pharmacotherapy for Severe Forms of TB
UNIV OF VIRGINIA · Principal Investigator
Oct 2017 – Dec 2018
Screening and Treatment of Children and Adults Exposed at Home to Drug-Resistant Tuberculosis
HARVARD MEDICAL SCHOOL · Principal Investigator
Aug 2017 ACTIVE
Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT)
BOSTON UNIV · Principal Investigator
Aug 2016 ACTIVE
Optimizing combination therapy for accelerate clinical cure of tuberculosis
NATL INST OF HLTH NIAID ·
Jul 2016 – May 2017
Pharmacokinetics of second-line anti-tuberculosis drugs among patients with multidrug-resistant tuberculosis
INTL SCIENCE AND TECHNOLOGY CENTER · Principal Investigator
Jun 2016 – Aug 2018
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
NATL INST OF HLTH NICHD ·
Feb 2016 – Jan 2018
MD-INMD Diagnostics and Pharmacotherapy for Service Year 2
UNIV OF VIRGINIA · Principal Investigator
Feb 2016 – Jan 2018
A Clinical Pharmacology Study of a Novel Drug Regimen for Pre XDR and XDR Tuberculosis
EMORY UNIV · Principal Investigator
Sep 2015 – Mar 2017
task A73: Combination drug testing for new TB regimens
TEXAS A&M RES FOU · Principal Investigator
Aug 2014 – Dec 2018
Rifampin and Lopinavir Study
UNIV OF MIAMI · Principal Investigator
Mar 2014 – Jun 2018
Pharmacokinetics and Pharmacodynamics of Tuberculosis Dr
CRITICAL PATH INSTITUTE · Principal Investigator
Feb 2014 – Feb 2017
Advanced Neuroimaging Evaluation of the Central Nervous
BRIGHAM AND WOMENS HOSPITAL · Principal Investigator
Feb 2014 – Jul 2017
Immune Activation and Drug Absorption in HIV-Infected Pa
DREXEL UNIVERSITY · Principal Investigator
Aug 2013 – Jul 2018
Phase 2 Pharmacodynamic Study of High-dose Levofloxacin in MDR-TB Treatment
BOSTON UNIV · Principal Investigator
Jul 2013 – Jun 2016
Intracavitary Drug Levels in Patients with Drug Resistan
EMORY UNIV · Principal Investigator
Jun 2009 ACTIVE
Moxifloxain PK in Bile.
MULTIPLE SPONSORS · Principal Investigator

Education

Pharm.D.
1986 · Philadelphia College of Pharmacy and Science
B.S.
1981 · University of Connecticut

Contact Details

Phones:
Business:
(352) 273-6266
Emails: